OFDT Documentation

  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact
Aide

Rechercher

Aide

Recherche avancée

Périodiques

Portail documentaire

  • A-
  • A
  • A+

Site OFDT

Historique

Accès réservé à l'OFDT et ses partenaires



Mot de passe oublié ?
  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact

Rechercher

Aide

Recherche avancée

Périodiques

  1. Accueil
  2. Retour
International Journal of Drug Policy, Vol.125 - March 2024
Ajouter à la sélection Ajouter à la sélection
Lien externe Lien externe
Bulletin de Périodique
International Journal of Drug Policy , Vol.125 - March 2024
Paru le : 01/03/2024
Année : 2024
Langue(s) : Anglais

Note de contenu :

CONTENTS:
- Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility. MacIsaac M.B., Whitton B., Anderson J., Cogger S., Vella-Horne D., Penn M., et al., art. 104317.
- Characterizing opioid overdose hotspots for place-based overdose prevention and treatment interventions: A geo-spatial analysis of Rhode Island, USA. Samuels E.A., Goedel W.C., Jent V., Conkey L., Hallowell B.D., Karim S., et al., art. 104322.
- The role of gifts in building influence with politicians: Thematic analysis of interviews with current and former parliamentarians. Rodriguez A.M.L., Adams P.J., Sayes E., Kypri K., art. 104332.
- The confluence of legacy, corporate social responsibility, and public health: The case of Migros and alcohol-free retailing in Switzerland. Klingemann H., Lesch M., art. 104333.
- Public opinion on the expenditure of adult-use cannabis tax revenue: Evidence from New Jersey. Link N.W., Hyatt J.M., Powell K., art. 104334.
- Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia. Lafferty L., Beadman M., Ward J., Flynn E., Hosseini-Hooshyar S., Martinello M., et al., art. 104335.
- Perceptions of prospective pharmaceutical stimulant substitution treatments among people who use illicit stimulants in Vancouver, Canada. Fleming T., Ivsins A., Barker A., Mansoor M., Mayer S., Vakharia S., et al., art. 104336.
- 'Just a colour?': Exploring women's relationship with pink alcohol brand marketing within their feminine identity making. Atkinson A.M., Meadows B.R., Sumnall H., art. 104337.
- Media framing xylazine as a "zombie drug" is amplifying stigma onto people who use drugs. Bowles J.M., Copulsky E.C., Reed M.K., art. 104338.
- Prescribed safer opioid supply: A scoping review of the evidence. Ledlie S., Garg R., Cheng C., Kolla G., Antoniou T., Bouck Z., et al., art. 104339.
- Using publicly available data to predict recreational cannabis legalization at the county-level: A machine learning approach. Montgomery B.W., Tong X., Vsevolozhskaya O., Anthony J.C., art. 104340.
- Popular media misinformation on neonatal abstinence syndrome, 2015-2021. McCreedy K., Chauhan A., Holder G., Kang S., Reinhart E., Beletsky L., art. 104341.
- Prosecuting overdose: An exploratory study of prosecutorial motivations for drug-induced homicide prosecutions in North Carolina. Morrissey B., El-Sabawi T., Carroll J.J., art. 104344.
- Trends and factors associated with illicit drug use in South Africa: Findings from multiple national population-based household surveys, 2002-2017. Mutai K.K., Stone J., Scheibe A., Fraser H., Johnson L.F., Vickerman P., art. 104352.
- Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals. Morphett K., Holland A., Ward S., Steadman K.J., Zwar N.A., Gartner C., art. 104353.
- People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study. Xavier J.C., McDermid J., Buxton J., Henderson I., Streukens A., Lamb J., et al., art. 104354.
Lien : https://www.sciencedirect.com/journal/international-journal-of-drug-policy/vol/125
Cote : Abonnement

Dépouillements

Ajouter le résultat à votre sélection
Media framing xylazine as a "zombie drug" is amplifying stigma onto people who use drugs [Commentary]

Media framing xylazine as a "zombie drug" is amplifying stigma onto people who use drugs [Commentary]

J. M. BOWLES ; E. C. COPULSKY ; M. K. REED | 2024
Dans International Journal of Drug Policy (Vol.125, March 2024) Article : Périodique
Amid increasing efforts to understand xylazine-associated harms, examining the potentially catastrophic role of stigma resulting from media outlets framing xylazine as the "zombie drug" is imperative. Zombies are cinematically depicted as soulle[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
'Just a colour?': Exploring women's relationship with pink alcohol brand marketing within their feminine identity making

'Just a colour?': Exploring women's relationship with pink alcohol brand marketing within their feminine identity making

A. M. ATKINSON ; B. R. MEADOWS ; H. SUMNALL | 2024
Dans International Journal of Drug Policy (Vol.125, March 2024) Article : Périodique
Background: The pinking of alcohol products and marketing (i.e. the (over) use of the colour pink as a feminine aesthetic) is a form of gendered marketing that is used by the industry to target and appeal to the female market, and encourage sale[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Nouvelle recherche Votre compte

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Suivez-nous

  • Traitement des données personnelles
  • Mentions légales
  • Plan du site